Moss Adams | 1 CPE | SEC Comment Letter Trends Among Life Sciences Companies
Understanding evolving compliance requirements is critical to prevent delays in periodic filings or filing for an initial public offering (IPO). The life sciences industry is no exception and resources such as SEC comments can provide valuable insight into how companies can avoid these setbacks.
Join us for our webcast, SEC Comment Letter Trends Among Life Sciences Companies. We’ll share the common SEC comments provided to life sciences companies from 2022 and 2023. Key topics include:
- Trends around management’s discussion and analysis (MD&A)
- SEC reporting, entity-related information, research and development, risk factors, and internal control over financial reporting (ICFR)
- Emerging disclosures over cybersecurity and climate-related risks